Managed the development of several drugs, 10 of them currently in the market. Examples of major NDA’s are Enalapril (Vasotec) and Lisinopril (Prinivil/Zestril).
• President and CEO, Transcend Therapeutics, Inc.,
• VP of Medical Affairs, Vertex Pharmaceuticals
• Executive Director, Novartis
• Director and Senior Director, Merck/MSDRL Corporation
• Chairman, DNAPrint Genomics, Inc.
• Scientific Advisor, Athena Capital Partners, Inc.

Was instrumental in closing and managing over $135 million in contract revenue for Pharm-Eco Laboratories
• CEO & President of Calix Corporation, parent company to Pharm-Eco Laboratories, Inc.
• Successfully completed the formation of several genetics, chemistry and pharma JVs, LLCs & spin-offs
• CEO & President, DNAPrint Genomics, Inc.
• Assisted in the development of: Amprenavir, Emtricitabine, Altretamine, Zalcitabine
• Over 30 IND’s/AND

Assisted over 28 clients with development and commercialization of over 30 products
• Founder & President, AcraPharm Consulting, Inc., providing CMC management and technical consulting services to pharmaceutical and bio-tech companies.
• Co-founder and VP, BioDevelopment Laboratories (BDL)
• Held several key executive and scientific positions at companies such as Arthur D. Little, Abbott Laboratories, G. D. Searle and Bristol-Myers.

• Residency, General Surgery and Plastic and Reconstructive Surgery
• Private practice for over ten years
• Advisory Board of Hernando Healthcare Inc.
• Chief of Staff, Brooksville Regional Hospital and Spring Hill Regional Hospital
• Clinical interest: skin cancers, melanoma, reconstructive surgery, hand surgery, and wound healing
• Research interest: include tumor immunology, cancer biology, and transplantation immunology

Had overall responsibility or played major role in planning, execution and submission of development programs of eleven approvable NDAs or PLAs.
• SVP Clinical Research, SCIREX CRO
• SVP R&D, Alpha Therapeutics
• VP, Clinical Research at the GHBA (Now Covance)
• VP, Clinical Development Operations at Medimmune (Division of Astra Zeneca)
• Director, Clinical Research, MSDRL

Held positions of CFO/ President with 5 early stage companies in the medical/pharmaceutical industry
• Has successfully raised over $30M of pre-venture capital for those companies
• Co-founder/President, Cytonics Corp.
• President, Atlas Spine, a spine implant company
• Founder/President of Doyen Medipharm,
• Vice Chairman of Jupiter’s Economic Development Advisory Board
• Chairman of the Early Stage Biotech Coalition